Inventiva IVA
NASDAQ IVA
$3.46 -0.23 (-6.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Inventiva (IVA) Income from Continuing Operations (2020 - 2021)

Updated

Inventiva's Income from Continuing Operations came in at -$159.27 million for FY2025, compared with -$100.83 million in FY2024.

Analysis

Inventiva (IVA) Income from Continuing Operations (2020 - 2021) Analysis & Trends

Going back to FY2018, Inventiva's Income from Continuing Operations data covers 8 years.

  • The FY2025 figure represents the lowest annual Income from Continuing Operations in data going back to FY2018.
  • Per Business Quant, earlier years put Income from Continuing Operations at -$100.83 million in FY2024, -$107.93 million in FY2023, -$51.11 million in FY2022 and -$51.64 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.28 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.09 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -246.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 Inventiva 713.04 Mn 713.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -11.89 Mn
Mar 31, 2021 -4.44 Mn
Jun 30, 2020 -9.70 Mn
Mar 31, 2020 -7.48 Mn
API Access

Inventiva Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=IVA&period=max&api_key=YOUR_API_KEY